Physician profile
Rosanta Marie Johnson
NPI 1225450489
$1,964.52
in general payments reported to CMS, 2019-2025
12 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Adult Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $644 · 2022: $1,072 · 2023: $128 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $601.01 | 2022-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $250.48 | 2021-2022 | |
| Boston Scientific Corporation | $202.79 | 2021-2022 | |
| Medtronic, INC. | $134.72 | 2021 | |
| Mayne Pharma Commercial LLC | $125.00 | 2022 | |
| Abbott Laboratories | $116.83 | 2022 | |
| Esperion Therapeutics, INC. | $115.75 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.21 | 2021 | |
| Janssen Pharmaceuticals, INC | $91.35 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.85 | 2021 | |
| Haemonetics Corporation | $75.40 | 2022 | |
| Gilead Sciences, INC. | $68.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosanta Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.